Dr. Karim Kader, associate clinical professor at the UC San Diego School of Medicine, together with a team of researchers from Wake Forest University School of Medicine, have developed a genetic test to predict a man’s risk for prostate cancer. Use of the test could reduce the need for repeat biopsies in men who have had a negative biopsy.
UC San Diego Health System is ranked among the nation’s best in U.S. News & World Report’s 23rd annual “America’s Best Hospitals” issue. The magazine ranked UC San Diego Health System #1 in the San Diego metropolitan area.
Dr. Allan Snavely, a widely recognized expert in high-performance computing whose innovative thinking led to the development of the Gordon supercomputer at the San Diego Supercomputer Center (SDSC) at UC San Diego, died of an apparent heart attack on Saturday, July 14. He was 49.
Researchers at the UC San Diego School of Medicine are evaluating a new social media tool called Wellaho to treat patients with type I and II diabetes. The clinical trial will study whether the use of social networking can improve patient-physician interactions and the patient’s overall health and wellbeing.
In a paper published in the July 11 online issue of Science Translational Medicine, researchers at the University of California, San Diego School of Medicine have identified two key regulatory proteins critical to clearing away misfolded proteins that accumulate and cause the progressive, deadly neurodegeneration of Huntington’s disease (HD).
Researchers at the University of California, San Diego School of Medicine say they have identified a set of laboratory-based biomarkers that can be useful for understanding brain-based abnormalities in schizophrenia. The measurements, known as endophenotypes, could ultimately be a boon to clinicians who sometimes struggle to recognize and treat the complex and confounding mental disorder.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
